Solitomab, an epithelial cell adhesion molecule/CD3 bispecific antibody (BiTE), is highly active against primary chemotherapy-resistant ovarian cancer cell lines in vitro and fresh tumor cells ex vivo

Author: English Diana P.   Bellone Stefania   Schwab Carlton L.   Roque Dana M.   Lopez Salvatore   Bortolomai Ileana   Cocco Emiliano   Bonazzoli Elena   Chatterjee Sudeshna   Ratner Elena   Silasi Dan-Arin   Azodi Masoud   Schwartz Peter E.   Rutherford Thomas J.   Santin Alessandro D.  

Publisher: Blackwell Publishing

E-ISSN: 1097-0142|121|3|403-412

ISSN: 0008-543X

Source: Cancer, Vol.121, Iss.3, 2015-02, pp. : 403-412

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content